Impact of insulin and metformin versus metformin alone on β-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes

Diabetes Care

Volumn 41, Issue 8, 2018, Pages 1717-1725

  Nadeau, Kristen J ^a   Hannon, Tamara S ^a   Edelstein, Sharon L ^a   Arslanian, Silva A ^a   Caprio, Sonia ^a   Leschek, Ellen W ^a   Zeitler, Philip S ^a   Buchanan, Thomas A ^a   Ehrmann, David A ^a   Mather, Kieren J ^a   Kahn, Steven E ^a  

^a Westat   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN GLARGINE; METFORMIN; INSULIN;

ADOLESCENT; ADULT; BODY MASS; CELL FUNCTION; CHILD; CHILDHOOD OBESITY; COMBINATION DRUG THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE DURATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIC CLAMP TECHNIQUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT RESPONSE; AGE; CLINICAL TRIAL; DRUG EFFECT; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; AGE FACTORS; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN GLARGINE; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; METFORMIN; YOUNG ADULT;

EID: 85053877938     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc18-0787     Document Type: Conference Paper

References (22)

1. Mayer-Davis EJ, Lawrence JM, Dabelea D, et al.; SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 2017; 376:1419-1429
2. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012; 366:2247-2256
3. Kahn SE, Haffner SM, Heise MA, et al.; ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355:2427-2443
4. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013; 36:1749-1757
5. Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the Diabetes Prevention Program: Effects of lifestyle intervention and metformin. Diabetes 2005; 54:2404-2414
6. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393-403
7. Weng J, Li Y, Xu W, et al. Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial. Lancet 2008; 371:1753-1760
8. The RISE Consortium. Restoring Insulin Secretion (RISE): Design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span. Diabetes Care 2014; 37:780-788
9. The RISE Consortium. Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic clamp. Diabetes Care 2018; 41:1696-1706
10. Hannon TS, Kahn SE, Utzschneider KM, et al.; The RISE Consortium. Review of methods for measuring β-cellfunction: Design considerations from the Restoring Insulin Secretion (RISE) Consortium. Diabetes Obes Metab 2018; 20:14-24
11. Andres R, Swerdloff R, Posefsky T, Coleman DL. Manual feedback technique for the control of blood glucose concentration. In Automation in Analytical Chemistry. Skeegs LT Jr., Ed. New York, Mediad, 1966, p. 486-491
12. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. AmJ Physiol 1979; 237:E214-E223
13. Elahi D. In praise of the hyperglycemic clamp. A method for assessment of β-cell sensitivity and insulin resistance. Diabetes Care 1996; 19:278-286
14. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984; 74:1318-1328
15. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42:1663-1672
16. Zellner A. An efficient method of estimating seemingly unrelated regression equations and tests for aggregation bias. J Am Stat Assoc 1962; 57:348-368
17. Srivastava VK, Giles DEA Seemingly Unrelated Regression Equations Models: Estimation and Inference. New York, Marcel Dekker, 1987
18. Henningsen A, Hamann J. Systemfit: a package for estimating systems of simultaneous equations in R. J Stat Softw 2007; 23:1-40
19. Hotelling H. The generalization of student's ratio. Ann Math Stat 1931; 2:360-378
20. American Diabetes Association. 2 Classification and diagnosis of diabetes: Standards of Medical Care in Diabetesd2018. Diabetes Care 2018; 41(Suppl. 1):S13-S27
21. The ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012; 367:319-328
22. Kahn SE, Lachin JM, Zinman B, et al.; ADOPT Study Group. Effects of rosiglitazone, glyburide, and metformin on β-cell function and insulin sensitivity in ADOPT. Diabetes 2011; 60:1552-1560